Amelogenesis imperfecta (AI) is a genetic disease affecting tooth enamel formation. AI can be an isolated entity or a phenotype of syndromes. To date, more than 10 genes have been associated with various forms of AI. We have identified 2 unrelated Turkish families with hypoplastic AI and performed mutational analysis. Whole-exome sequencing identified 2 novel heterozygous nonsense mutations in the ENAM gene (c.454G>T p.Glu152* in family 1, c.358C>T p.Gln120* in family 2) in the probands. Affected individuals were heterozygous for the mutation in each family. Segregation analysis within each family revealed individuals with incomplete penetrance or extremely mild enamel phenotype, in spite of having the same mutation with the other affected individuals. We believe that these findings will broaden our understanding of the clinical phenotype of AI caused by ENAM mutations.
t he outer surface of the human tooth is covered by dental enamel, which provides a beautiful appearance with a luster and enables efficient feeding with its exceptional hardness. To achieve such fine characteristics, enamel formation should be well coordinated throughout all the stages, including the presecretion, secretion, transition, and maturation stages. This coordination includes not just components of the extracellular matrix secreted by ameloblasts but also other genetic factors influencing the function of ameloblasts themselves.
Amelogenesis imperfecta (AI) is a group of hereditary diseases affecting tooth enamel formation. AI is heterogeneous in etiology as well as in phenotypes (Witkop, 1988) . Genes encoding enamel matrix proteins have been suspected as primary candidates of AI, and indeed, disease-causing mutations have been identified in AI patients. Mutations in amelogenin (AMELX; MIM *300391; Kim et al., 2004) , enamelin (ENAM; MIM *606585; Rajpar et al., 2001; Mardh et al., 2002) , enamelysin (MMP20; MIM *604629; Kim et al., 2005b) , and kallikrein 4 (KLK4; MIM *603767; P.S. Hart et al., 2004) have been identified by candidate gene approach. Genetic analysis approaches, such as linkage analysis, autozygosity mapping, and especially whole-exome sequencing, have identified new players in AI: family with sequence similarity 83 member H (FAM83H; MIM *611927; Kim et al., 2008) , WD repeatcontaining protein 72 (WDR72; MIM *613214; El-Sayed et al., 2009) , family with sequence similarity 20 member A (FAM20A; MIM *611062; O'Sullivan et al., 2011) , chromosome 3 open reading frame 26 (C4orf26; MIM *614829; Parry et al., 2012) , solute carrier family 24 member 4 (SLC24A4; MIM *609840; Parry et al., 2013) , laminin beta 3 (LAMB3; MIM *150310; Poulter et al., 2014b) , and integrin beta 6 (ITGB6; MIM *147558; Poulter et al., 2014a; Wang et al., 2014) .
Clinically, AI can be classified as hypoplastic, hypocalcification, and hypomaturation. Hypoplastic enamel is thin but hard in most cases. Hypocalcified enamel is very soft, and hypomatured enamel has reduced mineral density and brown discoloration. However, it is not possible or extremely difficult to determine the clinical phenotype exactly in some cases. Hypocalcified enamel is easily broken down after tooth eruption due to extreme softness, with the remaining surfaces being rough and discolored. In some cases, hypoplastic enamel occurs in combination with hypomaturation AI (Sundell and Valentin, 1986) .
Hypoplastic AI without other systemic conditions is caused as an X-linked pattern by mutations in the AMELX gene or as an autosomal pattern by mutations in the ENAM, LAMB3, and ITGB6 genes. In this study, we recruited 2 hypoplastic AI families and identified 2 novel nonsense ENAM mutations. Most interesting, in both families, we identified incomplete penetrance or an extremely mild clinical phenotype even though these individuals carried the same mutations as each proband.
MAtErIAls & MEthODs

Enrollment of human subjects
Two unrelated Turkish families having hypoplastic AI were recruited for the genetic studies. The study protocol was independently reviewed and approved by the Institution Review Board at Seoul National University Dental Hospital and University of Istanbul. Clinical examinations were performed, and blood samples were collected with the understanding and written consent of each participant according to the Declaration of Helsinki.
Whole-exome sequencing
Whole-exome sequencing was performed with DNA samples from the probands of the 2 AI families after exome capturing with NimblGen exome capture reagent (family 1) or Illumina TruSeq DNA sample prep kit (family 2); 75-bp (family 1) and 90-bp paired-end sequencing reads were obtained with Illumina HiSeq 2000 (Yale Center for Mendelian Genomics, West Haven, CT, USA; or Macrogen, Seoul, Korea). Sequencing reads were aligned to the NCBI human reference genome (NCBI build 37.2, hg19), and the sequence variations were annotated with dbSNP build 137.
polymerase chain reaction and sequencing
Identified variation in the ENAM gene was confirmed with Sanger sequencing, and segregation within each family was confirmed. DNA sequences of the primers and polymerase chain reaction (PCR) protocol were previously described (Kim et al., 2005a) . PCR amplifications were done with the HiPi DNA polymerase premix (Elpis Biotech, Taejeon, Korea), and PCR amplification products were purified with a PCR Purification Kit and protocol (Elpis Biotech). DNA sequencing was performed at a DNA sequencing center (Macrogen).
rEsults
Family 1
The proband was a ten-year-old girl presenting a localized form of hypoplastic AI from a consanguineous family ( Fig. 1A) . Whole-exome sequencing identified a novel guanine to thymine transversion in exon 7 of the ENAM gene (c.454G>T; Fig. 1B ). There was no other rare or novel variant in other AI candidate genes, including AMELX, AMBN, MMP20, KLK4, FAM83H, C4orf26, WDR72, SLC24A4, CNNM4, and FAM20A. This mutation changes glutamic acid (GAA) to the ochre termination codon (TAA) at codon position 152 (p.Glu152*). Because this mutation introduces an early termination codon that is not located in the last exon, the mutant mRNA would be degraded by the nonsense-mediated decay system so that no truncated protein could be generated. Sanger sequencing of the participating family members confirmed the existence of this mutation in the father (III:6), proband (IV:2), and sister of the proband (IV:1). All participating family members had uneventful pregnancy and delivery, and there was no systemic condition that could influence amelogenesis. Clinical examination revealed that the proband had hypoplastic regions located on the incisal half of the anterior permanent teeth with anterior open bite occlusion (Fig. 1C) . A panoramic radiograph showed that developing molars had hypoplastic enamel (Fig. 1D) . The affected father had many crowns and bridges, but the remaining teeth showed horizontal hypoplastic enamel regions, which are considered as a characteristic feature of ENAM mutations (Fig. 1E, 1F ). However, clinical examination could not detect any enamel defect related to the mutation in individual IV:1, who had the same ENAM mutation, even though she had several initial dental caries (both maxillary first molars and left mandibular first molar) and a restoration (right mandibular first molar; Fig. 1G, 1H ).
Family 2
The proband was an 11-year-old girl from a consanguineous marriage, who presented a localized form of hypoplastic AI ( Fig. 2A ). All participating family members had uneventful pregnancy and delivery, and there was no systemic condition. Whole-exome sequencing identified a novel cytosine-to-thymine transition in exon 7 of the ENAM gene (c.358C>T; Fig. 2B ). There was no other rare or novel variant in other AI candidate genes, including AMELX, AMBN, MMP20, KLK4, FAM83H, C4orf26, WDR72, SLC24A4, CNNM4, and FAM20A. This mutation changes glutamine (CAA) to the ochre termination codon (TAA) at codon position 120 (p.Gln120*). This nonsense mutation is also predicted to cause degradation of the mutant transcript, as in the case of family 1. The mutation was identified in the mother (III:6) as well as the brother of the proband (IV:2). The proband had a generalized thin enamel with some thick enamel in the middle of the mandibular permanent teeth and localized hypoplastic regions on the incisal half of the maxillary permanent teeth (Fig. 2C, 2D ). The affected mother had only several remaining teeth with gross destruction of the tooth structures ( Fig. 2E) . The brother of the proband had completely normal-looking mandibular permanent teeth; therefore, he was considered as a normal individual at the initial screening. The only abnormal enamel found was the regions on the incisal corners of the maxillary right lateral incisor, which resembled enamel fractures or dental caries (Fig. 2F) . At age 14 yr, poor oral hygiene resulted in dental caries in the maxillary central incisors and gingivitis (Fig. 2G ), but panoramic radiograph revealed normal-looking tooth structures (Fig. 2H ).
DIscussIOn
Enamelin, one of the major proteins in the enamel matrix, is essential for proper enamel formation. A knockout mouse model demonstrated deficient enamel mineralization, resulting in no true enamel but an irregularly mineralized thin layer covering normal dentin (Hu et al., 2008) . The dosage effect of enamelin was noted with the recessive ENAM mutations (T.C. and was further demonstrated by enamelin overexpressing transgenic mouse on the knockout background, indicating that an adequate quantity of enamelin is essential for normal enamel formation (Hu et al., 2014) .
Enamelin gene has been associated with dental caries susceptibility and recently identified as one of the genes contributing molar-incisor hypomineralization (Jeremias et al., 2013; Chaussain et al., 2014) . Even though specific structural change(s) or genetic element(s) has not been identified yet, it seems obvious that sequence variations and allelic predilection are related to caries susceptibility or molar-incisor hypomineralization.
Unlike other genes involved in AI, ENAM mutations frequently exhibit wide variable expressivity (even within a family), from minor enamel pits to severe enamel loss, where virtually no enamel is remaining (Kida et al., 2002; Chan et al., 2011) . It has been also noted that the same ENAM mutation results in different clinical phenotypes among families (P.S. . Phenotypic variation within family and between families is also shown in this study in spite of the similar nature of the mutations. A characteristic clinical feature frequently associated with ENAM mutations is horizontal hypoplastic grooves on the labial surface of the crown. The affected father of family 1 and the proband of family 2 also exhibit horizontal hypoplastic grooves.
Through the identification of recessive ENAM mutations, localized small enamel pits have been recognized as a milder phenotype of AI in heterozygous individuals (Table) . Individuals with ENAM mutations in both alleles exhibited severe generalized hypoplastic AI with open bite, indicating a dosage-dependent effect of the mutation (T.C. . Interestingly, the same mutation has been identified in other autosomal-dominant AI families with characteristic horizontal hypoplastic grooves, confirming the variable expressivity of ENAM mutations (Pavlic et al., 2007) .
Most striking, a sibling had normal-looking enamel despite having the same mutation (c.211-2A>C) with other affected family members (Kim et al., 2005a) . In this study, we identified additional cases of incomplete penetrance or extremely mild clinical phenotype with 2 different nonsense mutations. Recently, LAMB3 mutations have been identified to cause nonsyndromic AI by a dominant negative effect (Kim et al., 2013; Poulter et al., 2014b) , and a case with very mild expressivity has been noted in a truncating mutation with a prediction of a minimal dominant negative effect (Lee et al., 2014) .
The possibility of the hypoplastic AI with incomplete penetrance was noted in an epidemiologic study of Swedish population (Sundell and Valentin, 1986) . It is highly possible that among them, there were individuals having less harmful mutations in genes such as LAMB3, ENAM, ITGB6, or other yet Rajpar et al., 2001; Song et al., 2012 Exon 9 c.536G>T p.Arg179Met AD Gutierrez et al., 2007 Intron 9 c.588+1delG p.Asn197Ilefs*81 AD Kida et al., 2002; Kim et al., 2005a; Pavlic et al., 2007 Exon 10 c.1259-1260insAG p.Pro422Valfs*27 AR/AD T.C. Ozdemir et al., 2005; Pavlic et al., 2007; Kang et al., 2009; Chan et al., 2010; Lindemeyer et al., 2010 Exon 10 c.2991delT p.Leu998Trpfs*65 AD Kang et al., 2009 Sequences based on the reference sequence for mRNA (NM_031889.2) and protein (NP_114095.2), where the A of the ATG translation initiation codon is nucleotide 1.
unidentified genes; therefore, the phenotypes were variable and very mild in some cases. However, ENAM mutations with incomplete penetrance in a previous study and this study caused severe hypoplastic AI in other affected individuals. Generally, mutations in the ENAM gene cause hypoplastic enamel, but the severity of the enamel defects is sometimes highly variable, even among individuals with the same mutation. At this moment, there is no direct explanation or mechanism to support the lack of penetrance or extremely mild clinical phenotype in an individual. Other genetic factors, such as yet unidentified cis-or trans-acting elements, could regulate and influence the expression of enamelin or ENAM protein function. Further genetic and functional studies are needed to understand the dynamic and variable nature of enamel formation.
